Status:
UNKNOWN
Medication Optimisation for Reducing Events in a Private Practice Setting
Lead Sponsor:
Awenydd GmbH
Conditions:
Pharmacogenetic Analysis to Reduce Events.
Eligibility:
All Genders
18+ years
Brief Summary
Using a prospective study design of two three month periods (before and after genotyping) in which the patients will self-monitor their health status and possible medical events it is hypothesized tha...
Eligibility Criteria
Inclusion
- older than 18 years
- not demented
- 1 or more documented events in the previous 6 months.
- more than one medication
- multi-morbid
Exclusion
- demented
- life expectancy less than 1 year
- heart attack within the last 6 months
- Marcumar® Therapy
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00653653
Start Date
August 1 2008
End Date
October 1 2009
Last Update
April 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Awenydd Gmbh
Cologne, North Rhine-Westphalia, Germany, 50829